StageSeed VC | Dead
Medtep helps people understand the consequences of poor compliance by showing the real effect of their daily habits, personalized to their situation. uClinics (for healthcare professionals) and uPatient (for patients) are the two multi-platform applications that constitute the technological solution of Medtep. Dashboards are adapted to each preventive process or pathology. The information aggregated to the platform is shown in a manner that promotes awareness and patient proactivity, while it gives the healthcare professional the proper tools to provide a more personalized and timely care.
Missing: Medtep's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Medtep's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Medtep
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Medtep is included in 1 Expert Collection, including Digital Health.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Latest Medtep News
Jul 14, 2015
Posted on July 14, 2015 by Thomas Ohr Medtep , a cutting-edge online solution that brings digital therapeutics to disease prevention, treatment and wellness, announced today it has raised $2 million in seed funding. The funding round has been led by the Mexican Investment Fund Stella Maris Partners with the participation of other American and Spanish investors and business angels. The startup will use the fresh capital to ensure its internationalization strategy, focusing on the USA, LatAm and Europe. Medtep was founded in 2011 in Barcelona. I met the founders twice. The first time was right after they had started. I was impressed by their expertise and ambitions and quite sure they’re on their road to success! A few weeks ago the team moved to San Francisco and celebrated its 4th birthday. Today, Medtep has more than 20 large international contracts with key stakeholders in the sector. In the last trimester, Medtep reached more than 100,000 users who use its two sided platform to take control of their treatment and wellness by keeping track of different follow-up plans defined by healthcare professionals and personally adapted to users’ condition. Medtep helps people understand the consequences of poor compliance by showing the real effect of their daily habits, personalized to their situation. Their solution adapts to the specific and temporary conditions of the patient, fostering a behavioral change and improving the treatment compliance. Medtep complements and aggregates today’s medical histories, apps, sensors and devices—to unify and provide meaning to medical and lifestyle-related data. “This funding is a huge pledge of confidence in Medtep’s vision, as well as in the long term potential of our company” said Pablo Pantaleoni CEO of Medtep. “This capital gives us additional resources to expand quickly and strategically, especially in the USA and LatAm. We will be able to develop our roadmap rapidly and deliver our vision among patients and users around the world”.
Medtep Frequently Asked Questions (FAQ)
Where is Medtep's headquarters?
Medtep's headquarters is located at Van Ness & Market, San Francisco.
What is Medtep's latest funding round?
Medtep's latest funding round is Seed VC.
How much did Medtep raise?
Medtep raised a total of $2.06M.
Who are the investors of Medtep?
Investors of Medtep include Stella Maris Partners and Horizon 2020.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.